S. Danhauser-Riedl

1.4k total citations
34 papers, 1.1k citations indexed

About

S. Danhauser-Riedl is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, S. Danhauser-Riedl has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Hematology. Recurrent topics in S. Danhauser-Riedl's work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Synthesis and biological activity (3 papers). S. Danhauser-Riedl is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Synthesis and biological activity (3 papers). S. Danhauser-Riedl collaborates with scholars based in Germany, United States and Switzerland. S. Danhauser-Riedl's co-authors include Michael Hallek, W. E. Berdel, EF Winton, Markus Warmuth, Brian Druker, B. Emmerich, Johann Rastetter, Hermann Dietzfelbinger, Bertold Emmerich and Wolfgang E. Berdel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

S. Danhauser-Riedl

34 papers receiving 1.1k citations

Peers

Countries citing papers authored by S. Danhauser-Riedl

Since Specialization

Citations

This map shows the geographic impact of S. Danhauser-Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Danhauser-Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Danhauser-Riedl more than expected).

Fields of papers citing papers by S. Danhauser-Riedl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Danhauser-Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Danhauser-Riedl. The network helps show where S. Danhauser-Riedl may publish in the future.

Co-authorship network of co-authors of S. Danhauser-Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of S. Danhauser-Riedl. A scholar is included among the top collaborators of S. Danhauser-Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Danhauser-Riedl. S. Danhauser-Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NOTCH1 Mutation and Treatment Outcome In CLL Patients Treated With Chlorambucil (Chl) Or Ofatumumab-Chl (O-Chl): Results From The Phase III Study Complement 1 (OMB110911) 2013 ·Blood ·Eugen Tausch, Philipp Beck, Richard F. Schlenk, Sabrina Kless, (unknown), Peter Hillmen, Fritz Offner, Ann Janssens, (unknown), Sebastian Grosicki, Jiří Mayer, Panagiotis Panagiotidis, S. Danhauser-Riedl, Astrid McKeown, (unknown), Ira Gupta, Hartmut Döhner, Stephan Stilgenbauer	10
2	Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies 1999 ·Annals of Hematology ·Markus Warmuth, S. Danhauser-Riedl, Michael Hallek	60
3	Two Uncommon Lymphomas 1999 ·Journal of Clinical Oncology ·Ch. Jung, (unknown), Ursula Kronawitter, S. Danhauser-Riedl, F. D. Goebel, Detlef Schlöndorff	2
4	Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. 1997 ·PubMed ·Michael Hallek, Carola A. Neumann, Moshe Schaffer, S. Danhauser-Riedl, Nikolas von Bubnoff, Gabriele de Vos, Brian Druker, Kiyoshi Yasukawa, James D. Griffin, Bertold Emmerich	63
5	Interleukin‐6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP‐1 1996 ·European Journal of Immunology ·Carola A. Neumann, (unknown), S. Danhauser-Riedl, Bertold Emmerich, Michael Hallek	24
6	Interaction of the receptor tyrosine kinase p145^c‐kit with the p210^bcr/abl kinase in myeloid cells 1996 ·British Journal of Haematology ·Michael Hallek, S. Danhauser-Riedl, Ronald Herbst, Markus Warmuth, (unknown), (unknown), Brian Druker, J D Griffin, Bertold Emmerich, A. Ullrich	40
7	Interleukin 1 modulates growth of human renal carcinoma cells in vitro 1995 ·British Journal of Cancer ·Ina Koch, H. Depenbrock, S. Danhauser-Riedl, (unknown), (unknown)	15
8	Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD) 1993 ·Investigational New Drugs ·S. Danhauser-Riedl, (unknown), (unknown), (unknown), Hermann Dietzfelbinger, Johann Rastetter, (unknown)	111
9	Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents 1993 ·European Journal of Cancer ·(unknown), Susan G. Hilsenbeck, H. Depenbrock, S. Danhauser-Riedl, Thomas Block, H. Nekarda, (unknown), Matti Aapro, Marie-Christine Bissery, Johann Rastetter, A.-R. Hanauske	40
10	Effects of Recombinant Human Erythropoietin on Clonogenic Growth of Primary Human Tumor Specimens in vitro 1992 ·Oncology Research and Treatment ·Eileen Bauer, S. Danhauser-Riedl, Werner de Riese, (unknown), (unknown), H.-J. Meyer, (unknown), (unknown), M. Freund, H. Poliwoda, Johann Rastetter, Axel‐R. Hanauske	5
11	Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivo 1992 ·Cancer Letters ·Michael Koenigsmann, (unknown), S. Danhauser-Riedl, B. Reufi, William J. Houlihan, E. Thiel, Wolfgang E. Berdel	8
12	Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro. 1992 ·PubMed ·S. Danhauser-Riedl, Andreas Himmelmann, (unknown), Robert Busch, William R. Vogler, Johann Rastetter, W. E. Berdel	4
13	Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients 1991 ·Oncology Research and Treatment ·S. Danhauser-Riedl, (unknown), (unknown), U. Bruntsch, M. Peukert, H. Sindermann, H Präuer, J. R. Siewert	14
14	Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines. 1991 ·PubMed ·S. Danhauser-Riedl, Stephan B. Felix, William J. Houlihan, (unknown), (unknown), D Oberberg, (unknown), (unknown), Johann Rastetter, W. E. Berdel	22
15	Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro 1990 ·Cancer Chemotherapy and Pharmacology ·Andreas Himmelmann, S. Danhauser-Riedl, (unknown), Raymonde Busch, Edward J. Modest, Alessandro Noseda, Johann Rastetter, William R. Vogler, Wolfgang E. Berdel	9
16	Stimulation of Clonal Growth of Human Colorectal Tumor Cells by IL-3 and GM-CSF 1990 ·Oncology Research and Treatment ·Wolfgang E. Berdel, S. Danhauser-Riedl, (unknown), (unknown)	5
17	Antitumoral activity of a xanthate compound II. Therapeutic studies in murine leukemia and tumor models in vivo 1989 ·Cancer Letters ·Hans Schick, S. Danhauser-Riedl, Eberhard Amtmann, Robert Busch, Andreas S. Reichert, (unknown), Johann Rastetter, Gerhard Sauer, Wolfgang E. Berdel	5
18	Antitumoral activity of a xanthate compound I. Cytotoxicity studies with neoplastic cell lines in vitro 1989 ·Cancer Letters ·Hans Schick, Eberhard Amtmann, Wolfgang E. Berdel, S. Danhauser-Riedl, Andreas S. Reichert, (unknown), Johann Rastetter, Gerhard Sauer	11
19	Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeks 1988 ·Investigational New Drugs ·Michael Fromm, (unknown), (unknown), S. Danhauser-Riedl, U. Fink, (unknown), (unknown), (unknown), H Präuer, (unknown), Johann Rastetter	4
20	Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human nonseminomatous germ cell tumors growing in nude mice 1987 ·Cancer Letters ·Wolfgang E. Berdel, Martin R. Berger, (unknown), A. Harstrick, S. Danhauser-Riedl, Hans Schick, Hans‐Joachim Schmoll, D Schmähl, William R. Vogler, Johann Rastetter	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact